PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
27.06%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
316.29%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
1708.06%
Positive EBIT growth while JHX is negative. John Neff might see a substantial edge in operational management.
1708.06%
Positive operating income growth while JHX is negative. John Neff might view this as a competitive edge in operations.
132.28%
Positive net income growth while JHX is negative. John Neff might see a big relative performance advantage.
105.26%
Positive EPS growth while JHX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
105.26%
Positive diluted EPS growth while JHX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
11.99%
Share count expansion well above JHX's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
12.42%
Diluted share count expanding well above JHX's 0.15%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
328.66%
10Y revenue/share CAGR above 1.5x JHX's 35.58%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
2115.31%
5Y revenue/share CAGR above 1.5x JHX's 35.58%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.07%
3Y revenue/share CAGR 1.25-1.5x JHX's 35.58%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
459.71%
Net income/share CAGR 1.25-1.5x JHX's 316.52%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
91.12%
Below 50% of JHX's 316.52%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
58.88%
Below 50% of JHX's 316.52%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while JHX invests at 10.81%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.